First elected: 1st May 1997
Speeches made during Parliamentary debates are recorded in Hansard. For ease of browsing we have grouped debates into individual, departmental and legislative categories.
e-Petitions are administered by Parliament and allow members of the public to express support for a particular issue.
If an e-petition reaches 10,000 signatures the Government will issue a written response.
If an e-petition reaches 100,000 signatures the petition becomes eligible for a Parliamentary debate (usually Monday 4.30pm in Westminster Hall).
Protect Northern Ireland Veterans from Prosecutions
Gov Responded - 3 Jun 2025 Debated on - 14 Jul 2025 View Julian Lewis's petition debate contributionsWe think that the Government should not make any changes to legislation that would allow Northern Ireland Veterans to be prosecuted for doing their duty in combating terrorism as part of 'Operation Banner'. (1969-2007)
These initiatives were driven by Julian Lewis, and are more likely to reflect personal policy preferences.
MPs who are act as Ministers or Shadow Ministers are generally restricted from performing Commons initiatives other than Urgent Questions.
Julian Lewis has not been granted any Urgent Questions
Julian Lewis has not introduced any legislation before Parliament
Microplastic Filters (Washing Machines) Bill 2024-26
Sponsor - Alberto Costa (Con)
Terminal Illness (Relief of Pain) Bill 2024-26
Sponsor - Edward Leigh (Con)
Dogs (DNA Databases) Bill 2021-22
Sponsor - Andrew Griffith (Con)
June Bank Holiday (Creation) Bill 2019-21
Sponsor - Peter Bone (Ind)
Nuclear Submarine Recycling (Reporting) Bill 2017-19
Sponsor - Luke Pollard (LAB)
Armed Forces (Derogation from European Convention on Human Rights) Bill 2017-19
Sponsor - Leo Docherty (Con)
Armed Forces Covenant (Duty of Public Authorities) Bill 2017-19
Sponsor - Gavin Robinson (DUP)
Armed Forces (Statute of Limitations) Bill 2017-19
Sponsor - Lord Benyon (XB)
Foreign, Commonwealth and Development Office (FCDO) travel advice to Ukraine states: 'If you travel to Ukraine to fight, or to assist others engaged in the war, your activities may amount to offences under UK legislation. You could be prosecuted on your return to the UK'. Their full advice is available here: Ukraine travel advice - GOV.UK.
The Crown Prosecution Service (CPS), which acts independently of police and government, will consider any information that is referred by the police and any decision to prosecute will be considered on a case-by-case basis and in accordance with the Code for Crown Prosecutors.
To date, the CPS has not prosecuted any cases involving UK-linked foreign fighters in the conflict between Russia and Ukraine.
The Government is committed to righting past wrongs and working to ensure victims get answers. Inquiries shed light on injustices of the past, provide a means for victims and survivors to finally have their voices heard, and can help to rebuild trust in national institutions.
The Government recognises that there is growing criticism of Inquiry cost, duration and effectiveness.
The government is actively considering whether there are changes that could enable inquiries to deliver outcomes and enable lessons to be learnt more swiftly and at lower cost.
This is a substantial piece of work, led by the Cabinet Office, that will aim to improve how we identify wrongs, and get to the truth more quickly. We will continue to keep Parliament updated on this important subject.
‘Quangos’ is an obsolete term. They are now called Arm’s Length Bodies.
The list of all Government Arm’s Length Bodies (ALBs) can be found here [https://co-public-bodies.github.io/ALB_Landscape_Analysis_2023_24/08%20profilePagesIndex.html] along with the details of the 11 ALBs that Cabinet Office directly sponsors.
In April the Government announced a review of all ALBs across government with a view to streamline governance and reduce bureaucracy. This review is ongoing.
Members of the Senior Civil Service (SCS) are subject to an annual performance review process, governed by the central SCS performance management framework published on Performance management framework for the Senior Civil Service (2025 to 2026 performance year) - GOV.UK
The central framework is regularly reviewed to ensure that it is fit for purpose. Changes were introduced in April of this year, to ensure a greater focus on the productivity of the Senior Civil Service. This included the introduction of minimum standards, expected distribution and a cross-Government consistency check meeting.
The government will respond to the ISC regarding publication of its report on Iran in due course.
Departments publish email addresses as the first means of contacting Ministers. All departments have processes to ensure correspondence via email reaches the intended Minister or team in a rapid manner, meaning there should be no reduction in the ability of MPs to contact Ministers' private offices. MPs may, in any such email correspondence, request a phone call with a departmental official or a member of the Minister's private office.
The Government continues to consider the use of artificial intelligence in all Government services. The potential impacts of using these tools in responding to correspondence from Parliamentarians and members of the public, and the implications for the function of correspondence to hold the Government to account, will form part of the Government’s ongoing considerations.
The List of Ministerial Responsibilities, published on GOV.UK, provides Members of Parliament with contact details for each Government department. It provides a single point of contact for each department, through which all Members of Parliament can pursue constituents’ concerns. This policy has been in place since October 2023 and was introduced following security advice. As outlined in the Guide to Handling Correspondence, also published on GOV.UK, the default method of correspondence with Government departments is via official departmental email addresses.
The Government has been clear that non-disclosure agreements should not be misused by employers to conceal misconduct in the workplace. There are already legal limitations as to what NDAs can be used for, meaning the relevant clause would be unenforceable if it attempted to prevent a worker from whistleblowing, require a worker to cover up iniquity, or prevent a worker from doing anything that they may be required to do by law. We continue to look at how to make improvements to ensuring the misuse of NDAs is not used to conceal misconduct in the workplace.
British Steel closed its coke ovens in 2023, so is now reliant on imports of coke, a processed coal product. Since the passage of the Steel Industry (Special Measures) Act, British Steel has received coking coal from the United States of America, Colombia, and Australia. The company will keep its supply chains under review.
The Department for Business & Trade has not produced an assessment of the carbon footprint from the transportation of the coking coal required for the blast furnaces. However, the carbon footprint associated with transporting the coking coal to the UK can be calculated using publicly available data [such as the CarbonCare CO2 emissions calculator].
The previous Minister for Energy Consumers had discussions with industry, local government and devolved governments in the development of the Warm Homes Plan.
As the first step towards the Warm Homes Plan, the government committed an initial £3.4 billion over the next 3 years towards heat decarbonisation and household energy efficiency, with £1 billion of this allocated to 2025/2026.
The department has also launched the Warm Homes: Social Housing Fund (WH:SHF) to support social housing providers and tenants in England, and the Warm Homes: Local Grant (WH:LG) to support low-income homeowners and private tenants in England. Further detail on the Warm Homes Plan will be set out in October.
The Department works continually with Ofgem and the National Cyber Security Centre to ensure that regulations continue to capture the most critical operators of energy generation systems. Distributed and smaller-scale generation are key components of a smart and resilient energy system.
The Heath and Safety Executive and the North Sea Transition Authority are the relevant regulators for onshore shale gas extraction. They regulate compliance with the criteria set for plugging and abandoning wells at the end of their useful life.
The UK has a secure and diverse energy system. Over the past three years the market has successfully delivered sufficient supplies amidst a period characterised by high energy prices and uncertainties caused by Russia’s illegal invasion of Ukraine, and conflict in the Middle East. The National Emergency Plan for Downstream Gas and Electricity also sets out the arrangements for the safe and effective management of downstream gas or electricity disruption.
Decisions on whether to abandon wells are ultimately a matter for the company. Hydrocarbon wells must be safely plugged and abandoned when they are no longer in use.
Data on gas import origins (including imports of liquified natural gas (LNG) from the US) is published each month in Energy Trends table 4.4. Further disaggregation of US LNG by method of extraction is not collected or available.
The UK has no active commercial shale gas production and hence no emissions data from production to allow a comparison with emissions from imported gas.
The Department attaches great importance to providing timely responses to Member’s correspondence. Regrettably a processing error has severely delayed our response in this instance, for which the Department sincerely apologises. We are taking steps to correct this system to prevent further errors of this nature. We will provide a full response urgently.
The UK General Data Protection Regulation (UK GDPR) and the Data Protection Act 2018 (DPA) already require organisations to process personal data lawfully, fairly, transparently and securely, unless certain limited exemptions apply. Organisations are also required to meet additional conditions and safeguards when processing ‘special category’ data, or data that is more sensitive, such as DNA data.
The UK’s data protection legislation does not automatically prohibit the selling or sharing of personal data with third parties. Instead, it sets out a framework within which data sharing may safely take place.
The Information Commissioner’s Office (ICO), the UK’s Data Protection Regulator, has published a statutory Code of Practice on data sharing which contains practical guidance for organisations on how to share data fairly and lawfully, available at: https://ico.org.uk/for-organisations/uk-gdpr-guidance-and-resources/data-sharing/data-sharing-a-code-of-practice/.
The ICO has also published guidance to help organisations processing special category data, available at: https://ico.org.uk/for-organisations/uk-gdpr-guidance-and-resources/lawful-basis/a-guide-to-lawful-basis/special-category-data/.
The Online Safety Act 2023 places duties on social media companies and search services. These include duties to tackle illegal content on their services. These services will need to put systems and processes in place to reduce the risk that users post this illegal content. They will also need to take it down where it does appear. If companies fail to comply with any of these duties, Ofcom has a range of strong enforcement powers, including issuing fines and applying to the court to initiate business disruption measures.
Since 2010, the grant scheme has returned nearly £350 million to listed places of worship across the UK. This has helped protect our listed places of worship and enabled them to continue their work as centres of worship and community assets.
The scheme will now run until the end of March 2026. As was the case with previous Governments, further spending commitments are a matter for the Spending Review.
As a general rule, students are eligible for fee and maintenance loans only if they have settled status in the United Kingdom and have been ordinarily resident in the United Kingdom or the Republic of Ireland for three years. Students resident overseas are not eligible for loans.
The department and the Office for Students (OfS) have a programme of investigations underway. Where these investigations have found abuse of the student finance system, there will be serious consequences. We have now also asked the Public Sector Fraud Authority to tackle this threat and take forward this work across government. The department will always take steps to recover student loans that have been paid to students who have not been attending their courses. Depending on the precise circumstances, recovery has been and will continue to be pursued either from the institution or the student.
The department is consulting until 4 April on subcontracted provision. The consultation proposes changes to the requirements for courses to attract student finance that will necessitate subcontracted providers with specific numbers of students to be registered and regulated by the OfS. Together with the work of the OfS, which is currently consulting on reforms to its registration requirements, the department’s consultation will ensure subcontracted provision is better protected from poor quality and the risk of the misuse of public funding.
The department will also take immediate action on the use of agents to recruit students. The government can see no legitimate role for domestic agents in the recruitment of UK students. We are taking urgent steps to prevent any further abuse of the system.
Higher education (HE) providers are independent and therefore responsible for decisions around pay, including for Vice-Chancellors and other senior staff. The government does not have a role in intervening in pay and staffing matters.
The department acknowledges that Vice-Chancellors manage large and complex organisations, and therefore, deserve a salary that reflects the responsibilities and challenges of their roles.
However, Vice-Chancellors' salaries should not be excessive or disproportionate. Where providers are facing financial challenges, we expect them to work with staff and unions to help identify how best to reduce unnecessary spend. All efficiency measures taken by the sector should provide better long-term value both for students and for the country.
In addition, transparency is crucial for students, staff, and the public. Therefore, the Office for Students, the independent regulator in England, requires HE providers to provide and publish justifications for Vice-Chancellors' remuneration. If concerns arise regarding senior staff pay, the Office for Students has the authority to conduct independent reviews to ensure that a provider’s governance arrangements are appropriate and effective.
The Government is conducting a full review of all Arm’s Length Bodies. This review is ongoing, and the outcomes will be published in due course.
However, as National Parks are not classified as Arm’s Length Bodies, they are not included in the review.
The Prime Minister, Chancellor of the Duchy of Lancaster, Defra and MHCLG Secretaries of State and the Minister for Nature received a letter from the Campaign for National Parks on 7 October 2025 titled ‘Do not weaken the laws protecting National Parks and National Landscapes’. We will respond in due course.
The Government is working with a range of partners to consider the impact of the Protected Landscapes Duty. The duty is intended to facilitate better outcomes for England’s Protected Landscapes, which are in line with their statutory purposes.
The Government has published guidance on the Protected Landscapes duty to ensure public bodies operating in these areas, including water companies, deliver better environmental outcomes working together with Protected Landscape organisations.
I refer the Rt Hon Member to the answer I gave on 30 June 2025 to Question 62523. As a signatory of United Nations Convention on the Law of the Sea (UNCLOS), the UK Government adheres to international maritime law and protects the innocent passage of vessels transiting through UK waters.
The UK Government consistently monitors UK waters to uphold the safety of mariners, the marine environment and the UK’s national security, which includes monitoring of tankers that are suspected of being associated with the movement of Russian oil.
As a signatory of United Nations Convention on the Law of the Sea (UNCLOS), the UK Government adheres to international maritime law and protects the innocent passage of vessels transiting through UK waters.
The English National Concessionary Travel Scheme (ENCTS) provides free off-peak bus travel to those with eligible disabilities and those of state pension age. The ENCTS costs around £700 million annually and any changes to the statutory obligations, such as including companion passes, would therefore need to be carefully considered for its impact on the scheme’s financial sustainability.
The Department for Transport conducted a review of the ENCTS and is currently considering next steps. The review did not consider adding companion passes to the statutory criteria for the scheme.
Currently, local authorities in England have the power to go beyond their statutory obligations under the ENCTS and offer additional discretionary concessions, such as extending the travel time criteria for the ENCTS.
The government has confirmed £955 million for the 2025 to 2026 financial year to support and improve bus services in England outside London. This includes £243 million for bus operators and £712 million allocated to local authorities across the country. Hampshire County Council has been allocated £14 million of this funding. Funding allocated to local authorities to improve services for passengers can be used in whichever way they wish. This could include extending the discretionary concessions available in the local area to include companion passes.
The English National Concessionary Travel Scheme (ENCTS) provides free off-peak bus travel to those with eligible disabilities and those of state pension age, currently sixty-six. The ENCTS costs around £700 million annually and any changes to the statutory obligations, such as extending the eligibility criteria, would therefore need to be carefully considered for its impact on the scheme’s financial sustainability.
Local authorities in England have the power to go beyond their statutory obligations under the ENCTS and offer additional discretionary concessions, such as offering companion passes for those travelling with someone eligible for the ENCTS.
The Office for National Statistics (ONS) and National Records Scotland (NRS) publish annual data on deaths by sex and age group on their websites.
The decision not to set up a compensation scheme is now subject to live litigation and the High Court has granted permission for a full hearing.
In its response to the Public Accounts Committee (PAC) report on the AEA Technology case, the department agreed to consider the PAC recommendation to ‘ensure that people have an adequate route of appeal when considering complaints about their occupational and personal pensions, through a review of the Ombudsman’. Progress on the PAC and subsequent WPC recommendations were paused due to the General Election. The department remains committed to providing the PAC with an update once the Cabinet Office has considered how it would like departments to scope and schedule a new series of reviews for public bodies.
I refer the hon. Member to the answer I gave on 21 November 2025 to Question 85056.
The Department and NHS England are currently working at pace to develop plans on how best to improve the access, quality, and sustainability of all-age palliative care and end of life care in line with the 10-Year Health Plan.
We will closely monitor the shift towards the strategic commissioning of palliative and end of life care services to ensure that services reduce variation in access and quality, although some variation may be appropriate to reflect both innovation and the needs of local populations.
The Government is committed to protecting those most vulnerable to COVID-19 through vaccination, as guided by the independent Joint Committee on Vaccination and Immunisation (JCVI).
The primary aim of the national COVID-19 vaccination programme remains the prevention of serious illness, resulting in hospitalisations and deaths, arising from COVID-19. Population immunity to COVID-19 has been increasing due to a combination of naturally acquired immunity following recovery from infection and vaccine-derived immunity. COVID-19 is now a relatively mild disease for most people, though it can still be unpleasant, with rates of hospitalisation and death from COVID-19 having reduced significantly since COVID-19 first emerged.
The focus of the JCVI advised programme has therefore moved towards targeted vaccination of the two groups who continue to be at higher risk of serious disease, including mortality. These are the oldest adults and individuals who are immunosuppressed.
On 13 November 2024, the JCVI published advice on who should be offered vaccination in autumn 2025, and on 26 June 2025, the Government accepted the JCVI’s advice. The JCVI’s advice is available at the following link:
The UK Health Security Agency (UKHSA) continues to monitor COVID-19 through a variety of indicators and surveillance systems. Data over the last 12 months is not available by vaccination status. Information regarding the number of deaths from COVID-19 is available on the UKHSA data dashboard, at the following link:
https://ukhsa-dashboard.data.gov.uk/respiratory-viruses/covid-19#deaths
The UKHSA does not hold information regarding the likelihood of vaccinated and unvaccinated people aged between 50 and 75 years old contracting a long-covid infection.
The Department has made no assessment of the reasons for the difference in the availability of omaveloxolone (Skyclarys) as a treatment for Friedrich's ataxia in Scotland, England, and Wales.
Decisions on the availability of medicines are taken by the respective health authorities in each nation of the United Kingdom. The National Institute for Health and Care Excellence (NICE) is responsible for making recommendations on the use of new medicines in England, while Scotland has its own processes through the Scottish Medicines Consortium (SMC).
NICE publishes the reasons for its decisions on its website, and the Department has no plans to require NICE to set out the reasons for differences between its recommendations and the SMC’s. NICE was unable to make a recommendation on the use of omaveloxolone for treating Friedreich's ataxia in people aged 16 years old and over because the manufacturing company, Biogen, withdrew its evidence submission. NICE will review this decision if Biogen decides to make a new submission.
The Department has received correspondence about the NHS Hampshire and Isle of Wight Integrated Care Board’s (ICB) recent decision from ENT UK along with the British Rhinological Society, the Association of Otolaryngologists in Training, the British Society for Facial Plastic Surgery, and the patient charities SmellTaste and Sinus UK.
ICBs commission local services as part of their role in managing and improving healthcare for their populations. ICBs commission services to meet identified local needs and are responsible for planning how services will be delivered in their area. This includes making decisions about the routine procedures that are offered, based on evidence for how clinically effective they are. This means that nine clinical procedures, which have been available only in specific circumstances, will no longer be routinely funded.
Given this is an ICB policy, it would be their responsibility to undertake any impact assessments. The Clinical Professional Leadership Group leading on this clinical policy used expert guidance provided by the National Institute for Health and Care Excellence and a national evidence-based interventions programme. This decision reflects the group’s commitment to prioritising interventions that deliver the greatest equity and overall benefit to the health needs of the entire population. All patients with a nasal blockage and/or deformity will be offered alternative advice and treatment, and only in exceptional cases can clinicians apply for funding for these procedures if the treatment is felt to be appropriate.
The Department is committed to getting the National Health Service diagnosing prostate cancer earlier, and treating it faster, so that more patients survive.
The National Cancer audits are an essential tool in understanding variation in access to treatment across England and Wales. The NHS Cancer Programme’s workstream on treatment variation takes the recommendations from the ten cancer-focused audits and works with Cancer Alliances and the audit teams each year to assess and prioritise recommendations for focused action each year. Cancer Alliances work closely with their local specialty networks to identify and address opportunities to improve across their local areas. This includes taking action to address variation in over-treatment and under-treatment across the country.
Reducing inequalities and geographical variation in cancer care is a top priority for the Government. The National Cancer Plan, due for publication early next year, will set out further details on how we will improve outcomes for prostate cancer patients in all part of England.
There is no age limit on prostate specific antigen (PSA) tests.
Advice for general practitioners (GPs) called the Prostate Cancer Risk Management Programme provides information and guidance for GPs to counsel asymptomatic men about the potential benefits and harms of PSA testing so they can make an informed decision about whether to have the test. There is no routine testing of men using PSA. They are advised to follow National Institute for Health and Care Excellence (NICE) guidance for men who they think may have symptoms that could be prostate cancer. This includes the use of PSA as a diagnostic rather than screening test.
More information on the programme is available at the following link:
https://www.gov.uk/guidance/prostate-cancer-risk-management-programme-overview
With regards reimbursement of GP practices by the National Health Service for providing PSA tests, local enhanced services, such as blood tests, are negotiated and agreed locally, and are commissioned by integrated care boards to fit the needs of the local population. GP practices can choose whether they would like to participate in providing these services. These services can vary in scope and funding across the country. We have not assessed the potential impact of this funding arrangement for PSA tests on GP willingness to provide testing.
Where a man is symptomatic of prostate cancer, NICE guidance is clear about using the PSA test in these men. The guidance is available at the following link:
The National Disease Registration Service (NDRS) in NHS England collects diagnosis and treatment data on cancer patients in England. NDRS does not hold information on the specific results of the prostate specific antigen test in the format requested.
The Parliamentary Under-Secretary of State for Patient Safety, Women’s Health and Mental Health, Baroness Merron, is the Minister with responsibility for life sciences and innovation, and cell and gene therapies are included in this remit.
In September 2024, the Department stood up an advanced therapies co-ordination group which aims to create a joined-up ecosystem that will support the development, regulation, and delivery of advanced therapy medicinal products in the United Kingdom. This group is chaired at the Senior Civil Service Grade 1 level. We note the recent report from the Cell and Gene Collective, titled Tomorrow’s Science, Today’s NHS, including the ask for a Minister to chair the group, and we will consider the report’s recommendations in due course.
Improving the early diagnosis of cancer, including lobular breast cancer, is a priority for NHS England. The National Health Service will improve cancer survival rates and hit all NHS cancer waiting time targets, so that no patient waits longer than they should.
To increase awareness of lobular breast cancer, NHS England and other NHS organisations, nationally and locally, publish information on the signs and symptoms of breast cancer. Further information can be found on the NHS.UK website, which is available at the following link:
The NHS Breast Screening Programme offers all women in England between the ages of 50 and 71 years old the opportunity to be screened every three years for breast cancer, to help detect abnormalities and intervene early to reduce the number of lives lost to breast cancer. However, lobular breast cancer is difficult to detect using imaging scans, such as mammogram.
The Department invests £1.5 billion each year on research through its research delivery arm, the National Institute for Health and Care Research (NIHR). NIHR research expenditure for all cancers was £133 million in 2023/24 reflecting its high priority.
The Department has invested £29 million into the Institute of Cancer Research and the Royal Marsden NIHR Biological Research Centre in 2022, supporting their efforts to strengthen research into cancer, including lobular breast cancer. Wider investments into breast cancer research include a £1.3 million project to determine whether an abbreviated form of breast magnetic resonance imaging can detect breast cancers missed by screening through mammography, including lobular breast cancer.
The Department continues to work closely with NHS England on the development of the National Cancer Plan to achieve the overall goal of fewer lives lost to cancer, including to lobular breast cancer. The plan will be published later this year.
The National Institute for Health and Care Excellence (NICE) is the independent, expert body that develops evidence-based guidelines for the National Health Service on best practice. While the NICE currently has no plans to issue guidance on paediatric acute-onset neuropsychiatric syndrome (PANS) and paediatric autoimmune neuropsychiatric disorder associated with streptococcus (PANDAS), should the evidence base develop further, we would look to the NICE to update clinical policy.
In the meantime, integrated care systems are responsible for planning care for their populations’ conditions, and clinicians will want to take account of any new research and developments in guidance, such as those being overseen by the PANS PANDAS Steering Group, to ensure that they can continue to provide high quality care to their patients.
Integrated care boards (ICBs) are responsible for the commissioning of palliative and end of life care services, including for children and young people, to meet the needs of their local populations. To support ICBs in this duty, NHS England has published statutory guidance and service specifications.
NHS England has a legal duty to annually assess the performance of each ICB in respect of each financial year, and to publish a summary of its findings. This assessment must include how well the ICB has discharged its functions.
Tackling waiting lists is a key part of our Health Mission and we are taking steps to return to the 18-week standard. The Elective Reform Plan sets out how the National Health Service will reform elective care services to meet the 18-week referral to treatment standard by March 2029.
There are nine specialist mesh centres across England, ensuring that women in every region with complications of mesh inserted for urinary incontinence and vaginal prolapse get the right support. Each mesh centre is led by a multi-disciplinary team to ensure patients get access to the specialist care and treatment that they need, including pain management and psychological support. NHS England publishes data on referral to treatment waiting times, which is available at the following link:
https://www.england.nhs.uk/statistics/statistical-work-areas/rtt-waiting-times/
Data is published at the level of specialties, for example gynaecology, and is not routinely published at sub-speciality level. The most recent waiting time data held by NHS England from 2024 indicated that the average waiting time across the nine centres was 28 weeks.
The surgery to remove mesh implanted for stress urinary incontinence and vaginal prolapse is a relatively new surgical discipline. Expertise is, therefore, concentrated in a limited number of specialist centres led by a core multi-disciplinary team, including consultant specialists in urogynaecology, urology, and pain management. Patients, when requesting treatment for mesh complications, can exercise patient choice and be referred to another centre, ensuring that they can be seen by another surgeon where appropriate.
NHS Resolution (NHSR) manages clinical negligence and other claims against the National Health Service in England, and while the information is not available in the format requested, they have provided the data below. This information only covers England and not the rest of the United Kingdom, and NHSR has interpreted ‘in court’ as being where the court proceedings have been served, rather than where a case has gone to trial.
Claims notified and open are not guaranteed to be settled in the same year and can take many years to be concluded. Claims notified in any given year will often relate to incidents that have occurred many years prior. Claims closed and settled in one year will often relate to claims notified in different years. Many of the claims notified will have been repudiated and settled without damages paid.
It is also possible that the same claim may appear more than once in a dataset, across different year groups, for example, where the case has been closed as unsuccessful, challenged, reopened, and closed again at conclusion.
The following table shows the number of clinical claims and incidents received between the financial years 2014/15 and 2023/24, where the claim has been identified as a vaginal mesh claim:
Year of notification | Number of claims |
2014/15 | 5 |
2015/16 | 12 |
2016/17 | 15 |
2017/18 | 54 |
2018/19 | 70 |
2019/20 | 209 |
2020/21 | 396 |
2021/22 | 226 |
2022/23 | 166 |
2023/24 | 99 |
Total | 1,252 |
Source: NHSR
In addition, the following table shows the number of clinical claims settled between the financial years 2015/16 and 2023/24 with a damages payment, where the claim has been identified as a vaginal mesh claim, broken down by litigation status:
Year of settlement and litigation status | Number of claims |
2015/16 | # |
Litigation | # |
No Litigation | # |
2016/17 | # |
Litigation | # |
No Litigation | # |
2017/18 | 16 |
Litigation | 8 |
No Litigation | 8 |
2018/19 | # |
Litigation | 8 |
No Litigation | # |
2019/20 | # |
Litigation | 11 |
No Litigation | # |
2020/21 | 32 |
Litigation | 22 |
No Litigation | 10 |
2021/22 | 61 |
Litigation | 19 |
No Litigation | 42 |
2022/23 | 116 |
Litigation | 27 |
No Litigation | 89 |
2023/24 | 101 |
Litigation | 22 |
No Litigation | 79 |
Total | 356 |
Source: NHSR
Finally, the following table shows the number of clinical claims settled between the financial years 2015/16 and 2023/24 with no damages paid, where the claim has been identified as a vaginal mesh claim, broken down by litigation status:
Year of settlement and litigation status | Number of claims |
2015/16 | # |
Litigation | # |
No Litigation | 8 |
2016/17 | # |
Litigation | # |
No Litigation | 6 |
2017/18 | # |
Litigation | # |
No Litigation | 7 |
2018/19 | 43 |
Litigation | 5 |
No Litigation | 38 |
2019/20 | # |
Litigation | # |
No Litigation | 43 |
2020/21 | 90 |
Litigation | 6 |
No Litigation | 84 |
2021/22 | 167 |
Litigation | 64 |
No Litigation | 103 |
2022/23 | 179 |
Litigation | 28 |
No Litigation | 151 |
2023/24 | 120 |
Litigation | 10 |
No Litigation | 110 |
Total | 678 |
Source: NHSR
Notes: NHSR has supressed low figures as NHSR believe that disclosure of information to a member of the public would contravene one or more of the data protection principles. In some instances, for low numbers of claims, namely fewer than 5, in each category, the likelihood exists that individuals who are the subject of this information may be identified. As this information is sensitive personal data, NHSR believes it has a greater responsibility to protect those individuals’ identities, as disclosure could potentially cause damage and/or distress to those involved. Due to small numbers in the tables, NHSR has used a ‘#’ symbol in the relevant field.